Superales, Junrel P.
HRN: 16-41-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
AMPICILLIN 250MG (VIAL)
04/17/2023
04/24/2023
IVTT
105mg
Q12
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes